載入中
McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.
前收盤價
US$938.84
+US$8.59 · +0.92%
盤中時間採用ET。市場資料可能有所延遲。
McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.
日內區間
目前US$938.84
52週區間
目前US$938.84
盤中時間採用ET。市場資料可能有所延遲。
McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.
日內區間
目前US$938.84
52週區間
目前US$938.84
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2026會計年度 | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 |
|---|---|---|---|---|---|
| 營收 | 4034.3億 USD | 3590.51億 USD | 3089.51億 USD | 2767.11億 USD | 2639.66億 USD |
| 銷貨成本 | 3888.8億 USD | 3465.66億 USD | 2967.49億 USD | 2648.42億 USD | 2513.17億 USD |
| 毛利 | 145.5億 USD | 124.85億 USD | 122.02億 USD | 118.69億 USD | 126.49億 USD |
| 研究與開發 | 1.03億 USD | 9100萬 USD | 7700萬 USD | 8900萬 USD | 7000萬 USD |
| 銷售、一般及管理費用 | −80.96億 USD | 80.22億 USD | 81.98億 USD | 73.27億 USD | 98.56億 USD |
| 營業費用 | 80.96億 USD | 81.13億 USD | 82.75億 USD | 74.16億 USD | 99.26億 USD |
| 利息收入 | 1.79億 USD | 1.73億 USD | 1.18億 USD | 1.07億 USD | 1000萬 USD |
| 利息支出 | 2.47億 USD | 2.56億 USD | 2.43億 USD | 2.48億 USD | 1.78億 USD |
| 折舊和攤銷 | 7.29億 USD | 6.36億 USD | 6.35億 USD | 6.08億 USD | 7.6億 USD |
| 營業利益 | 64.54億 USD | 43.72億 USD | 39.27億 USD | 44.53億 USD | 27.23億 USD |
| 淨利 | 47.62億 USD | 32.95億 USD | 30.02億 USD | 35.6億 USD | 11.14億 USD |
公司資料更新於 2026年10月11日。
近期已公布業績
近期已公布業績
第三方分析師預期可能變動，並非 GoAI 建議。
平均目標
US$956.43
上漲空間 1.87%報告持有此股票曝險的交易所交易基金。
State Street SPDR S&P 500 ETF1557.T2092.79億0.16%129.35兆 JPY0.09%¥122,850—
Vanguard Morningstar Total Stock Market ETFVTI33.81億0.14%2.3兆 USD0.03%US$381.94—
Vanguard S&P 500 ETFVOO28.26億0.16%1.8兆 USD0.03%US$715.59—
iShares Core S&P 500 ETFIVV14.42億0.16%8964.4億 USD0.03%US$781.97—
State Street SPDR S&P 500 ETFSPY13.22億0.16%8172億 USD0.09%US$778.57—
Vanguard Morningstar Value ETFVTV10.17億0.39%2624億 USD0.03%US$220.59—
State Street Health Care Select Sector SPDR ETFXLV7.72億1.77%435.37億 USD0.08%US$170.81—
Vanguard Dividend Appreciation ETFVIG6.02億0.45%1324億 USD0.04%US$239.05—State Street SPDR S&P 500 ETF1557.TVanguard Morningstar Total Stock Market ETFVTIVanguard S&P 500 ETFVOOiShares Core S&P 500 ETFIVVState Street SPDR S&P 500 ETFSPYVanguard Morningstar Value ETFVTVState Street Health Care Select Sector SPDR ETFXLVVanguard Dividend Appreciation ETFVIGAI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
